How Cochlear Implant Rehabilitation Impacts the Therapeutic Strategy for Vestibular Schwannoma.

Autor: Iannacone FP; Department of Neuroscience DNS, Otolaryngology Section, University of Padova, 35100 Padova, Italy., Visconti F; Department of Neuroscience DNS, Otolaryngology Section, University of Padova, 35100 Padova, Italy., Zanoletti E; Department of Neuroscience DNS, Otolaryngology Section, University of Padova, 35100 Padova, Italy.
Jazyk: angličtina
Zdroj: Audiology research [Audiol Res] 2023 Feb 08; Vol. 13 (1), pp. 116-129. Date of Electronic Publication: 2023 Feb 08.
DOI: 10.3390/audiolres13010012
Abstrakt: Background: Since both surgery and more conservative treatments show long-term outcomes in patients with VS, the current challenge in its therapeutic strategy is to offer a cure with lower functional morbidity in terms of facial and hearing preservation or the possibility of hearing rehabilitation with a cochlear implant.
Methods: PubMed and Scopus databases were searched from 2017 to November 2022. Fifteen articles met our selection criteria: (1) patients with a diagnosis of VS, either sporadic or NF2-related; (2) simultaneous or sequential cochlear implantation; (3) specified audiological test results and follow-up timing.
Conclusions: Although the level of evidence for the presently included studies is low due to either the study design or the lack of treatment consensus, CI rehabilitation is a promising option, especially in small VS with compromised hearing and as a salvage option after a failed attempt at hearing preservation surgery.
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje